Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Adigbli

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
BMJ Case Reports|December 17, 2015
Airway management of a life-threatening post-thyroidectomy haematomaGeorge Adigbli, Jonathan King
Transplantation|February 19, 2020
Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease, and Regenerative MedicineGeorge Adigbli, Séverine Ménoret, Amy R Cross, et al.
Frontiers in Immunology|April 19, 2021
Development of LT-HSC-Reconstituted Non-Irradiated NBSGW Mice for the Study of Human Hematopoiesis <i>In Vivo</i>George Adigbli, Peng Hua, Masateru Uchiyama, et al.
Journal of the American Academy of Dermatology|March 23, 2025
Tumor-infiltrating lymphocyte scoring improves progression risk prediction in stage II melanoma: A retrospective cohort studyGeorge Adigbli, Benedict Reed, Bhavika Khera, et al.
European Journal of Immunology|July 28, 2021
Chimeric antigen receptor-modified human regulatory T cells that constitutively express IL-10 maintain their phenotype and are potently suppressiveYasmin R Mohseni, Adeel Saleem, Sim L Tung, et al.
Blood|June 30, 2020
The BET inhibitor CPI203 promotes ex vivo expansion of cord blood long-term repopulating HSCs and megakaryocytesPeng Hua, Joanna Hester, George Adigbli, et al.
Postgraduate Medical Journal|May 19, 2025
Medical Students' Insight into Foundation Training (MEDSIFT): a National Cross-Sectional Online Survey reveals close to 50% are considering a career outside the NHSBenjamin Cook, Edelyne Tandanu, Umar Rehman, et al.
JAMA Dermatology|April 9, 2025
Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous MelanomaSerigne N Lo, Caroline Gjorup, Annette Hougaard Chakera, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
BMJ Case Reports|December 17, 2015
Airway management of a life-threatening post-thyroidectomy haematomaGeorge Adigbli, Jonathan King
Transplantation|February 19, 2020
Humanization of Immunodeficient Animals for the Modeling of Transplantation, Graft Versus Host Disease, and Regenerative MedicineGeorge Adigbli, Séverine Ménoret, Amy R Cross, et al.
Frontiers in Immunology|April 19, 2021
Development of LT-HSC-Reconstituted Non-Irradiated NBSGW Mice for the Study of Human Hematopoiesis <i>In Vivo</i>George Adigbli, Peng Hua, Masateru Uchiyama, et al.
Journal of the American Academy of Dermatology|March 23, 2025
Tumor-infiltrating lymphocyte scoring improves progression risk prediction in stage II melanoma: A retrospective cohort studyGeorge Adigbli, Benedict Reed, Bhavika Khera, et al.
European Journal of Immunology|July 28, 2021
Chimeric antigen receptor-modified human regulatory T cells that constitutively express IL-10 maintain their phenotype and are potently suppressiveYasmin R Mohseni, Adeel Saleem, Sim L Tung, et al.
Blood|June 30, 2020
The BET inhibitor CPI203 promotes ex vivo expansion of cord blood long-term repopulating HSCs and megakaryocytesPeng Hua, Joanna Hester, George Adigbli, et al.
Postgraduate Medical Journal|May 19, 2025
Medical Students' Insight into Foundation Training (MEDSIFT): a National Cross-Sectional Online Survey reveals close to 50% are considering a career outside the NHSBenjamin Cook, Edelyne Tandanu, Umar Rehman, et al.
JAMA Dermatology|April 9, 2025
Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous MelanomaSerigne N Lo, Caroline Gjorup, Annette Hougaard Chakera, et al.
Pageof 1